NextCure Inc (NAS:NXTC)
$ 1.17 0 (0%) Market Cap: 32.77 Mil Enterprise Value: -37.15 Mil PE Ratio: 0 PB Ratio: 0.43 GF Score: 40/100

NextCure Inc Annual Shareholders Meeting Transcript

Jun 11, 2020 / 02:00PM GMT
Release Date Price: $24.13 (-4.98%)
David S. Kabakoff
NextCure, Inc. - Independent Chairman of the Board

Good morning, and welcome to the 2020 Annual Meeting of the Stockholders of NextCure, Inc., our first annual meeting as a public company.

I'm David Kabakoff, Chair of the Board of Directors of NextCure. We're holding this meeting virtually over the Internet in order to ensure that the health and welfare of our stockholders, directors and management in the light of the COVID pandemic and to enable us to reach more stockholders and make it easier for them to participate than would be the case with an in-person meeting.

To all of our stockholders, I wish the best for you, your families and your communities in these unprecedented times. There are 2 items of business on today's agenda: first, the election of Class I directors; and second, the ratification of the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for 2020.

I will act as the chair of the meeting. (Operator Instructions) In addition, after the business portion of the meeting, we will answer

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot